Poland· PL-100392907
Neosine duo
A medicinal product containing inosinum pranobexum + zinci gluconas, registered in Poland by Aflofarm Farmacja Polska Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Inosinum pranobexum + Zinci gluconas
- Manufacturer
- Aflofarm Farmacja Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991385613
- gtin05909991385620
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/82d8fcf0-e7b4-4973-8129-97d446ef50a8 GET /v1/drugs/82d8fcf0-e7b4-4973-8129-97d446ef50a8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Syrop",
"source": "urpl",
"strength": "(500 mg + 3,125 mg Zn 2+)/5 ml",
"packaging": "05909991385613 ¦ Rp ¦ 129940\n1 butelka 150 ml\n05909991385620 ¦ Rp ¦ 129941\n1 butelka 100 ml",
"substance": "Inosinum pranobexum 500 mg/5 ml + Zinci gluconas 21.7 mg/5 ml",
"common_name": "Inosinum pranobexum + Zinci gluconas",
"pl_product_id": "100392907",
"pozwolenie_nr": "24952",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about inosinum pranobexum + zinci gluconas.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.